Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27Eleftherios P Mamounas, Stewart J Anderson, James J Dignam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27Harry D Bear, Stewart Anderson, Ann Brown, et al.Annals of Surgical Oncology|April 15, 2006
Tumor bed boost omission after negative re-excision in breast-conservation treatmentDouglas W Arthur, Laurie W Cuttino, Andrew C Neuschatz, et al.Journal of Surgical Oncology|April 14, 2017
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trialHarry D Bear, Wen Wan, André Robidoux, et al.Journal of Translational Medicine|April 2, 2011
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressureMaciej Kmieciak, Kyle K Payne, Michael O Idowu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2011
Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CTKaren A Kurdziel, Joseph D Kalen, Jerry I Hirsch, et al.Journal of Leukocyte Biology|July 10, 2018
Gr1-/low CD11b-/low MHCII+ myeloid cells boost T cell anti-tumor efficacyKyle K Payne, Hussein F Aqbi, Savannah E Butler, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
Cutting edge: mast cells critically augment myeloid-derived suppressor cell activitySheinei J Saleem, Rebecca K Martin, Johanna K Morales, et al.Journal of Leukocyte Biology|March 11, 2014
Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cellsRebecca K Martin, Sheinei J Saleem, Lauren Folgosa, et al.BMC Immunology|February 29, 2020
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancerAndrea J Luker, Laura J Graham, Timothy M Smith, et al.Pageof 9